Lifestyle changes paired with diabetes drug may lower cancer risk for women MD Anderson researchers focus on the combination of the diabetes prevention drug, metformin, and a lifestyle intervention of diet and physical activity to determine how they relate to outcomes for people at risk for endometrial cancer, the most common gynecologic cancer linked to obesity.